October is Breast Cancer Awareness Month (BCAM). Breast Cancer is the most common type of cancer among women.
This month people all over the world show their support for individuals affected by breast cancer. The number of BCA campaigns increases each year proving more help and information to patients and caregivers.
GCT has a vast experience conducting oncology clinical research. Recently, we have initiated a Phase I Breast Cancer study to assess the efficacy, tolerance and PK parameters of the investigational product designed to treat Breast Cancer in Women.
We are grateful to have the opportunity to make our own contribution to the common cause.